Preview

Obstetrics, Gynecology and Reproduction

Advanced search

To the question on vaccination of pregnant women during COVID-19 pandemic

https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.170

Full Text:

Abstract

The pandemic of the novel coronavirus disease 2019 (COVID-19) makes us to think about effective preventive methods in pregnant women, because the course of such infection is accompanied by a high risk of severe endotheliopathy, disseminated intravascular coagulation, septic shock, thromboembolic complications and maternal mortality. Undoubtedly, vaccination is the most effective method of protection during pandemic, which experience in some infections in pregnant women has been accumulated in the world practice and may be also used for the COVID-19 vaccine. Here we discuss the issues of vaccination for pregnant women to expand the view of medical doctors and eliminate prejudice against immunization of pregnant women.

About the Authors

E. Yu. Yupatov
Kazan State Medical Academy - branch of Russian Medical Academy of Continuing Professional Education, Health Ministry of Russian Federation
Russian Federation
Evgenii Yu. Yupatov - MD, PhD, Associate Professor, Head of Department of Obstetrics and Gynecology, Kazan State Medical Academy.
36 Butlerova Str., Kazan 420015.


L. I. Maltseva
Kazan State Medical Academy - branch of Russian Medical Academy of Continuing Professional Education, Health Ministry of Russian Federation
Russian Federation
Larisa I. Maltseva - MD, Dr Sci Med, Professor, Department of Obstetrics and Gynecology, Kazan State Medical Academy.
36 Butlerova Str., Kazan 420015.


N. Z. Yusupova
Kazan State Medical Academy - branch of Russian Medical Academy of Continuing Professional Education, Health Ministry of Russian Federation
Russian Federation
Nailya Z. Yusupova - MD, Dr Sci Med, Professor, Head of the Department of General Hygiene, Kazan State Medical Academy.
36 Butlerova Str., Kazan 420015.


L. Z. Safina
Kazan State Medical Academy - branch of Russian Medical Academy of Continuing Professional Education, Health Ministry of Russian Federation
Russian Federation
Luiza Z. Safina - MD, PhD, Associate Professor, Department of Pediatrics with the Course of Outpatient Pediatrics.
36 Butlerova Str., Kazan 420015.


E. G. Ignashina
Ministry of Health of the Republic of Tatarstan
Russian Federation
Elena G. Ignashina - MD, PhD, Head of the Department for Organization of Medical Care for Children and Obstetrics Service, Ministry of Health of the Republic of Tatarstan.
11/6 Ostrovsky Str., Kazan 420111.


T. E. Kurmanbaev
S.M. Kirov Military Medical Academy, Ministry of Defense of Russian Federation
Russian Federation
Timur E. Kurmanbaev - MD, PhD, Faculty Member, Department of Obstetrics and Gynecology, S.M. Kirov Military Medical Academy, Ministry of Defense of Russian Federation.
6 Klinicheskaya Str., Saint Petersburg 194044.


K. M. Atayants
S.M. Kirov Military Medical Academy, Ministry of Defense of Russian Federation
Russian Federation
Karine M. Atayants - MD, PhD, Faculty Member, Department of Obstetrics and Gynecology, S.M. Kirov Military Medical Academy, Ministry of Defense of Russian Federation.
6 Klinicheskaya Str., Saint Petersburg 194044.


A. A. Shmidt
S.M. Kirov Military Medical Academy, Ministry of Defense of Russian Federation
Russian Federation
Andrey A. Shmidt - MD, PhD, Associate Professor, Colonel of Medical Service, Head of the Department of Obstetrics and Gynecology, S.M. Kirov Military Medical Academy, Ministry of Defense of Russian Federation.
6 Klinicheskaya Str., Saint Petersburg 194044.


References

1. Huntley B.J.F., Huntley E.S., Di Mascio D. et al. Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) infection: a systematic review. Obstet Gynecol. 2020;136(2):303-12. https://doi.org/10.1097/AOG.0000000000004010.

2. Di Mascio D., Khalil A., Saccone G. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2):100107. https://doi.org/10.1016/j.ajogmf.2020.100107.

3. Zaigham M., Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99(7):823-9. https://doi.org/10.1111/aogs.13867.

4. Mullins E., Evans D., Viner R.M. et al. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol. 2020;55(5):586-92. https://doi.org/10.1002/uog.22014.

5. Hantoushzadeh S., Shamshirsaz A.A., Aleyasin A. et al. Maternal death due to COVID-19 disease. Am J Obstet Gynecol. 2020;223:109.e1-16. https://doi.org/10.1016/j.ajog.2020.04.030.

6. Alzamora M.C., Paredes T., Caceres D. et al. Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol. 2020;37(8):861-5. https://doi.org/10.1055/s-0040-1710050.

7. Vivanti A.J., Vauloup-Fellous C., Prevot S. et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020;11(1):3572. https://doi.org/10.1038/s41467-020-17436-6.

8. Zeng L., Xia S., Yuan W. et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr. 2020;174(7):722-5. https://doi.org/10.1001/jamapediatrics.2020.0878.

9. Dong L., Tian J., He S. et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA. 2020;323(18):1846-8. https://doi.org/10.1001/jama.2020.4621.

10. Kimberlin D.W., Stagno S. Can SARS-CoV-2 infection be acquired in utero? More definitive evidence is needed. JAMA. 2020;323(18):1788-9. https://doi.org/10.1001/jama.2020.4868.

11. Boonyaratanakornkit J., Chu H.Y. Why should we advocate maternal immunization? Pediatr Infect Dis J. 2019;38(6S Suppl 1):S28-S32. https://doi.org/10.1097/INF.0000000 000002312.

12. Kourtis A.P., Read J.S., Jamieson D.J. Pregnancy and infection. N Engl J Med. 2014;370(23):2211-8. https://doi.org/10.1056/NEJMra1213566.

13. Jones C.E., Calvert A., Le Doare K. Vaccination in pregnancy - recent developments. Pediatr Infect Dis J. 2018;37(2):191-3. https://doi.org/10.1097/INF.0000000000001822.

14. Wilcox C.R., Holder B., Jones C.E. Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy. Front Immunol. 2017;8:1294. https://doi.org/10.3389/fimmu.2017.01294.

15. Calvert A., Jones C.E. Placental transfer of antibody and its relationship to vaccination in pregnancy. Curr Opin Infect Dis. 2017;30(3):268-73. https://doi.org/10.1097/QCO.0000000000000372.

16. Dangor Z., Nunes M.C., Kwatra G. et al. Vaccination of HIV-infected pregnant women: implications for protection of their young infants. Trop Dis Travel Med Vaccines. 2017;3:1. https://doi.org/10.1186/s40794-016-0044-7.

17. Andreas N.J., Kampmann B., Mehring Le-Doare K. Human breast milk: a review on its composition and bioactivity. Early Hum Dev. 2015;91(11):629-35. https://doi.org/10.1016/j.earlhumdev.2015.08.013.

18. ACOG Committee Opinion No. 741: Maternal immunization. Obstet Gynecol. 2018;131(6):e214-e217. https://doi.org/10.1097/AOG.0000000000002662.

19. Khan R., Vandelaer J., Yakubu A. et al. Maternal and neonatal tetanus elimination: from protecting women and newborns to protecting all. Int J Womens Health. 2015;7:171-80. https://doi.org/10.2147/IJWH.S50539.

20. Rasmussen S.A., Jamieson D.J., Bresee J.S. Pandemic influenza and pregnant women. Emerg Infect Dis. 2008;14(1):95-100. https://doi.org/10.3201/eid1401.070667.

21. Mosby L.G., Rasmussen S.A., Jamieson D.J. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol. 2011;205(1):10-8. https://doi.org/10.1016/j.ajog.2010.12.033.

22. Nunes M.C., Madhi S.A. Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: a systematic review and meta-analysis. Hum Vaccin Immunother. 2018;14(3):758-66. https://doi.org/10.1080/21645515.2017.1345385.

23. Madhi S.A., Cutland C.L., Kuwanda L. et al.; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014;371(10):918-31. https://doi.org/10.1056/NEJMoa1401480.

24. Moro P.L., Broder K., Zheteyeva Y. et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol. 2011;204(2):146.e1-7. https://doi.org/10.1016/j.ajog.2010.08.050.

25. Irving S.A., Kieke B.A., Donahue J.G. et al. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol. 2013;121(1):159-65. https://doi.org/10.1097/AOG.0b013e318279f56f.

26. Kharbanda E. O., Vazquez-Benitez G., Lipkind H. et al. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol. 2013;122(3):659—67. https://doi.org/10.1097/AOG.0b013e3182a1118a.

27. Meijer W.J., van Noortwijk A.G.A., Bruinse H.W., Wensing A.M.J. Influenza virus infection in pregnancy: a review. Acta Obstet Gynecol Scand. 2015;94(8):797-819. https://doi.org/10.1111/aogs.12680.

28. Marshall H., McMillan M., Andrews R.M. et al. Vaccines in pregnancy: the dual benefit for pregnant women and infants. Hum Vaccin Immunother. 2016;2(4):848-56. https://doi.org/10.1080/21645515.2015.1127485.

29. Blanchard-Rohner G., Eberhardt C. Review of maternal immunisation during pregnancy: focus on pertussis and influenza. Swiss Med Wkly. 2017;147:w14526. https://doi.org/10.4414/smw.2017.14526.

30. Cornia P.B., Hersh A.L, Lipsky B.A. et al. Does this coughing adolescent or adult patient have pertussis? JAMA. 2010;304(8):890-6. https://doi.org/10.1001/jama.2010.1181.

31. Carcione D., Regan A.K., Tracey L. et al. The impact of parental postpartum pertussis vaccination on infection in infants: A populationbased study of cocooning in Western Australia. Vaccine. 2015;33(42):5654-61. https://doi.org/10.1016/j.vaccine.2015.08.066.

32. Pickering L.K., Baker C.J., Freed G.L. et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(6):817-40. https://doi.org/10.1086/605430.

33. Krubiner C.B., Faden R.R., Karron R.A. et al. Pregnant women & vaccines against emerging epidemic threats: ethics guidance for preparedness, research, and response. Vaccine. 2019;S0264-410X(19)30045-3. https://doi.org/10.1016/j.vaccine.2019.01.011. [Online ahead of print].

34. Zhao X., Jiang Y., Zhao Y. et al. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening. Eur J Clin Microbiol Infect Dis. 2020;39:1209-20. https://doi.org/1007/s10096-020-03897-6.

35. Li C.C., Wang X.J., Wang H.R. Repurposing host-based therapeutics to control coronavirus and influenza virus. Drug Discov Today. 2019;24(3):726-76. https://doi.org/10.1016/j.drudis.2019.01.018.

36. Makatsariya A.D., Bitsadze V.O., Khizroeva J.Kh. et al. Novel coronavirus infection (COVID-19) and risk groups in obstetrics and gynecology. Akusherstvo, Ginekologia i Reprodukcia. 2020;14(2):159-62. https://doi.org/10.17749/2313-7347.133

37. Ellington S., Strid P., Tong V.T. et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22 - June 7, 2020. MMWR. 2020;69(25):769-75. https://doi.org/10.15585/mmwr.mm6925a1.

38. Collin J., Bystrom E., Carnahan A., Ahrne M. Public Health Agency of Sweden's brief report: pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden. Acta Obstet Gynecol Scand. 2020;99(7):819-22. https://doi.org/10.1111/aogs.13901.

39. Khalil A., von Dadelszen P., Draycott T. et al. Change in the incidence of stillbirth and preterm delivery during the COVID-19 pandemic. JAMA. 2020;324(7):705-6. https://doi.org/10.1001/jama.2020.12746.

40. Prompetchara E., Ketloy C., Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38(1):1-9. https://doi.org/10.12932/AP-200220-0772.


For citation:


Yupatov E.Yu., Maltseva L.I., Yusupova N.Z., Safina L.Z., Ignashina E.G., Kurmanbaev T.E., Atayants K.M., Shmidt A.A. To the question on vaccination of pregnant women during COVID-19 pandemic. Obstetrics, Gynecology and Reproduction. 2020;14(5):656-666. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.170

Views: 46


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)